Nebraska Medical Center

Nebraska Medical Center was paid $76.40M by Medicaid between Jan 2018 and Dec 2024, across 759 billing codes. Its largest line is 99284, emergency room visit (serious) — 7.0% of everything it billed.

33Billing provider infoNEBRASKA MEDICAL CENTER
OMAHA, NE 68198

33aNPI1356307581assigned 04/25/2006

33bProvider typeEmergency Medicine Physician

28Total paid$76.40M

24GClaims3,035,702

24DCodes billed759

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Emergency Medicine Physician providers in Nebraska

Rank by total paid#1 of 22

Median peer was paid$109K

This provider vs. median704×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	390,948	$9.63M
2019	386,958	$9.94M
2020	389,615	$9.58M
2021	779,528	$18.85M
2022	711,836	$18.34M
2023	278,665	$7.43M
2024incomplete	98,152	$2.63M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	7.0%	44,021	39,087	$5.32M
41899	Unlisted procedure, dentoalveolar structures	6.2%	7,893	7,160	$4.70M
96361	Intravenous infusion, hydration; each additional hour	5.4%	16,809	12,545	$4.12M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.6%	22,800	19,742	$2.77M
G0378	Hospital observation service, per hour	2.7%	12,820	8,700	$2.03M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.6%	8,934	8,116	$2.01M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	2.5%	308,781	244,456	$1.88M
70450	Computed tomography, head or brain; without contrast material	2.1%	7,416	6,700	$1.64M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.1%	15,987	14,627	$1.59M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.9%	4,063	3,872	$1.48M
0202U	Oncology (prostate), multianalyte, gene expression profiling	1.9%	4,977	4,673	$1.42M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.8%	21,913	7,854	$1.39M

747 more codes

70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.6%	3,482	$1.20M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.5%	7,228	$1.13M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.5%	10,829	$1.11M
71260	Computed tomography, thorax, diagnostic; with contrast material	1.4%	6,631	$1.09M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.4%	4,518	$1.04M
J0585	Injection, onabotulinumtoxina, 1 unit	1.2%	3,065	$918K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.1%	25,817	$848K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	1.0%	11,546	$796K
36512		1.0%	253	$783K
80053	Comprehensive metabolic panel	1.0%	138,723	$770K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	7,907	$703K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	8,090	$694K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,158	$640K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	25,913	$638K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,691	$630K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	21,105	$524K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	137,746	$497K
71046	Radiologic examination, chest; 2 views	<1%	18,211	$494K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,328	$494K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	370	$461K
J3490	Unclassified drugs	<1%	97,496	$455K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,656	$437K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	427	$425K
87631		<1%	4,303	$418K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	4,899	$412K
59025	Fetal non-stress test	<1%	2,830	$399K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	32,599	$387K
Q3014	Telehealth originating site facility fee	<1%	27,595	$371K
J2323	Injection, natalizumab, 1 mg	<1%	242	$368K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	4,441	$347K
74183		<1%	993	$347K
84443	Thyroid stimulating hormone (TSH)	<1%	33,165	$341K
99152		<1%	7,096	$338K
76818		<1%	3,524	$333K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	18,270	$326K
78815	Positron emission tomography (PET) for limited area imaging	<1%	326	$310K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	7,147	$310K
96415		<1%	1,741	$309K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,071	$308K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	14,459	$303K
36415	Collection of venous blood by venipuncture	<1%	117,113	$287K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	13,465	$284K
95806		<1%	865	$284K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	9,273	$272K
20610		<1%	1,686	$258K
83655		<1%	16,878	$251K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	9,803	$242K
93308		<1%	746	$240K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,308	$232K
83036	Hemoglobin; glycosylated (A1C)	<1%	29,700	$229K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	598	$223K
93975		<1%	2,914	$213K
90670		<1%	3,171	$213K
82805		<1%	3,941	$212K
97165		<1%	3,253	$209K
90686		<1%	14,222	$208K
93976		<1%	2,173	$202K
71250		<1%	2,034	$200K
93971		<1%	1,748	$198K
90651		<1%	2,036	$191K
70486		<1%	2,078	$186K
31575		<1%	727	$185K
64615		<1%	553	$182K
76801		<1%	2,776	$180K
90837	Psychotherapy session, about an hour	<1%	4,473	$173K
80048	Basic metabolic panel (calcium, ionized)	<1%	34,874	$171K
88142		<1%	8,119	$170K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	464	$169K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	5,091	$166K
80197		<1%	17,684	$165K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,848	$163K
80061	Lipid panel	<1%	22,729	$161K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	975	$160K
90834	Psychotherapy session, about 45 minutes	<1%	4,986	$160K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	10,863	$160K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	10,209	$159K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,906	$158K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	852	$153K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	20,269	$153K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,050	$149K
36591		<1%	4,823	$149K
64643		<1%	300	$143K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,722	$138K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	769	$137K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,369	$136K
93970		<1%	930	$136K
49083		<1%	323	$136K
87086	Culture, bacterial; quantitative colony count, urine	<1%	21,149	$134K
76536		<1%	1,096	$133K
90715		<1%	6,620	$132K
J7030	Infusion, normal saline solution , 1000 cc	<1%	25,634	$127K
85027		<1%	29,272	$126K
92557		<1%	1,784	$125K
83880		<1%	8,641	$124K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	9,932	$123K
92134		<1%	3,507	$121K
77336		<1%	1,086	$121K
73630		<1%	3,877	$121K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	986	$119K
73610		<1%	3,583	$118K
72100		<1%	3,070	$118K
90791	Psychiatric diagnostic evaluation	<1%	2,105	$118K
J1756	Injection, iron sucrose, 1 mg	<1%	1,742	$117K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	179	$116K
76641		<1%	960	$115K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,814	$115K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	103,875	$115K
81025		<1%	22,562	$113K
87480		<1%	11,337	$113K
70496		<1%	471	$112K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	180	$110K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,181	$109K
70491		<1%	439	$109K
70355		<1%	2,527	$108K
84439		<1%	12,348	$108K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	150	$107K
J1453	Injection, fosaprepitant, 1 mg	<1%	600	$106K
96375	Therapeutic injection; each additional sequential IV push	<1%	17,119	$105K
97597		<1%	772	$105K
83735		<1%	40,213	$103K
87660		<1%	11,495	$103K
92083		<1%	3,030	$102K
87536		<1%	2,585	$100K
73030		<1%	3,448	$98K
97161		<1%	3,209	$96K
73562		<1%	2,863	$93K
93798		<1%	1,659	$93K
86850		<1%	8,318	$92K
87510		<1%	11,334	$91K
82728		<1%	9,990	$91K
73130		<1%	2,747	$90K
82607		<1%	8,371	$90K
87497		<1%	2,868	$86K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	17,341	$85K
83970		<1%	3,003	$84K
93321		<1%	1,301	$84K
96417		<1%	1,428	$84K
J2704	Injection, propofol, 10 mg	<1%	10,931	$82K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	729	$82K
86780		<1%	9,014	$80K
73560		<1%	2,576	$80K
76820		<1%	980	$79K
86923		<1%	1,831	$78K
90677		<1%	779	$77K
88307		<1%	1,107	$76K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,802	$73K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	2,031	$73K
73110		<1%	2,242	$71K
94618		<1%	391	$71K
90472	Immunization administration, each additional vaccine (list separately)	<1%	4,378	$70K
73502		<1%	2,227	$70K
95812		<1%	201	$68K
95886		<1%	797	$68K
90832	Psychotherapy session, about 30 minutes	<1%	2,126	$67K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	4,340	$66K
81003		<1%	27,745	$66K
77080		<1%	1,542	$65K
72040		<1%	1,813	$65K
87081		<1%	8,892	$64K
87507		<1%	204	$63K
58300		<1%	472	$62K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	108	$62K
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	30	$61K
86900		<1%	9,548	$61K
86140		<1%	10,173	$60K
94375		<1%	1,615	$59K
90750		<1%	894	$59K
94729		<1%	1,732	$59K
77063	Screening digital breast tomosynthesis, bilateral	<1%	3,431	$57K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	3,249	$57K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	5,008	$55K
93325		<1%	580	$55K
72141		<1%	366	$55K
77386		<1%	234	$54K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	18,005	$53K
71045	Radiologic examination, chest; single view	<1%	8,553	$53K
92250		<1%	1,792	$52K
86803		<1%	6,072	$52K
97162		<1%	2,726	$51K
99213	Doctor's office visit, returning patient (routine)	<1%	5,342	$51K
31231		<1%	317	$51K
0097U		<1%	500	$50K
87340		<1%	6,658	$50K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	913	$50K
84484		<1%	20,453	$50K
74018		<1%	1,804	$49K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	77	$49K
73590		<1%	1,956	$49K
J0897	Injection, denosumab, 1 mg	<1%	189	$49K
85610		<1%	19,775	$48K
94060		<1%	978	$48K
88341		<1%	1,298	$48K
36592		<1%	1,710	$48K
99153	Mod sedat endo service >5yrs	<1%	4,475	$47K
76830	Ultrasound, transvaginal	<1%	1,997	$47K
74174		<1%	341	$47K
73552		<1%	1,370	$47K
90734		<1%	1,086	$46K
84466		<1%	7,444	$46K
88342		<1%	2,543	$45K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	14,408	$45K
72156		<1%	299	$45K
84100		<1%	24,369	$45K
96367		<1%	1,977	$45K
12001		<1%	210	$44K
86235		<1%	3,891	$44K
76770		<1%	324	$44K
76819	Fetal biophysical profile; without non-stress testing	<1%	545	$44K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	290	$44K
70498		<1%	536	$43K
86762		<1%	3,323	$43K
94761		<1%	5,986	$43K
94726		<1%	1,405	$43K
84702		<1%	3,571	$42K
A0210	Non-emergency transportation: ancillary: meals-escort	<1%	3,929	$42K
86480		<1%	1,362	$42K
82784		<1%	5,287	$42K
J7050	Infusion, normal saline solution, 250 cc	<1%	17,323	$41K
87522	Neg quan hep c or qual rna	<1%	1,351	$41K
A9270	Non-covered item or service	<1%	61,936	$41K
90680		<1%	1,636	$41K
93296		<1%	1,812	$41K
70320		<1%	572	$41K
87077		<1%	8,287	$41K
83540		<1%	9,731	$40K
0099U		<1%	331	$40K
36430		<1%	816	$40K
92550		<1%	425	$40K
82570		<1%	10,973	$39K
A0180	Non-emergency transportation: ancillary: lodging-recipient	<1%	2,579	$39K
90732		<1%	2,003	$39K
82746		<1%	4,953	$38K
97535	Self-care/home management training, each 15 minutes	<1%	1,417	$37K
93017		<1%	385	$37K
93225		<1%	658	$37K
88185		<1%	680	$36K
0124A		<1%	1,217	$36K
96411		<1%	182	$35K
96523		<1%	682	$35K
J0475	Injection, baclofen, 10 mg	<1%	111	$35K
80074		<1%	1,954	$35K
86787		<1%	3,753	$34K
C8957	Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump	<1%	206	$34K
92133		<1%	1,680	$34K
72197		<1%	130	$33K
76882		<1%	259	$33K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,495	$33K
A4217	Sterile water/saline, 500 ml	<1%	6,467	$33K
71275	Computed tomographic angiography, chest, with contrast material	<1%	333	$32K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	1,027	$32K
87799		<1%	2,086	$32K
73140		<1%	895	$32K
96401		<1%	981	$32K
86359		<1%	1,701	$31K
84403		<1%	2,131	$31K
90647		<1%	1,981	$31K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	482	$30K
87070		<1%	4,911	$30K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	87	$30K
81001		<1%	21,819	$30K
87186		<1%	5,483	$30K
76642		<1%	201	$30K
99156		<1%	1,116	$29K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	11,098	$29K
93350		<1%	167	$28K
90633		<1%	1,236	$28K
0001A		<1%	966	$28K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,915	$27K
93922		<1%	613	$27K
83690		<1%	12,163	$26K
84145		<1%	4,533	$26K
86901		<1%	9,444	$26K
86360		<1%	1,020	$26K
74178		<1%	110	$25K
72170		<1%	1,049	$25K
83516		<1%	2,945	$25K
83605		<1%	12,584	$25K
97116		<1%	1,786	$25K
0002A		<1%	802	$24K
77300		<1%	185	$24K
77334		<1%	164	$24K
88184		<1%	764	$23K
96376		<1%	4,865	$23K
83021		<1%	1,875	$23K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	15,370	$22K
71271		<1%	274	$22K
97166		<1%	480	$22K
93458		<1%	12	$22K
86255		<1%	2,937	$22K
85007		<1%	7,396	$22K
67028	Intravitreal injection of a pharmacologic agent	<1%	162	$21K
85018		<1%	7,326	$21K
76380		<1%	220	$21K
73080		<1%	716	$21K
86832		<1%	854	$20K
C1769	Guide wire	<1%	2,652	$20K
93246		<1%	405	$20K
20553		<1%	129	$20K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	6,764	$20K
88304		<1%	1,209	$20K
17110		<1%	123	$19K
80076		<1%	2,950	$19K
82105		<1%	2,051	$19K
86706		<1%	2,415	$19K
87486		<1%	609	$19K
87581		<1%	609	$19K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	117	$18K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	16,563	$18K
12011		<1%	101	$18K
82043		<1%	6,043	$18K
82977		<1%	3,204	$18K
90723		<1%	1,871	$18K
11981		<1%	50	$18K
J1644	Injection, heparin sodium, per 1000 units	<1%	4,583	$17K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	850	$17K
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	5,828	$17K
94664		<1%	2,008	$17K
84153		<1%	1,672	$17K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	3,585	$17K
90662		<1%	1,908	$17K
J0690	Injection, cefazolin sodium, 500 mg	<1%	4,704	$17K
97035		<1%	399	$17K
85652		<1%	6,073	$16K
87529		<1%	667	$16K
95117		<1%	856	$16K
90620		<1%	161	$16K
72070		<1%	507	$16K
82803		<1%	1,755	$16K
84481		<1%	1,607	$16K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	5,546	$15K
0003A		<1%	668	$15K
83615		<1%	4,842	$15K
93226		<1%	320	$15K
82950		<1%	2,824	$15K
83550		<1%	1,901	$14K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	289	$14K
72157		<1%	103	$14K
84146		<1%	1,093	$14K
87205		<1%	4,521	$14K
J3535	Drug administered through a metered dose inhaler	<1%	2,468	$14K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	1,812	$14K
0004A		<1%	544	$14K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,759	$14K
85379		<1%	5,689	$14K
93925		<1%	158	$14K
87210		<1%	3,953	$14K
95874		<1%	1,241	$13K
11982		<1%	44	$13K
83520		<1%	1,867	$13K
0352U		<1%	760	$13K
84156		<1%	5,749	$13K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	244	$13K
87040		<1%	3,538	$12K
95813		<1%	38	$12K
86833		<1%	780	$12K
76813		<1%	154	$12K
86355		<1%	636	$12K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	139	$12K
76775		<1%	146	$12K
10060		<1%	67	$12K
86704		<1%	1,542	$12K
82670		<1%	758	$12K
73090		<1%	544	$11K
82330		<1%	4,079	$11K
96416		<1%	38	$11K
83001		<1%	979	$11K
82378		<1%	1,275	$11K
86256		<1%	1,346	$11K
20550		<1%	46	$11K
41874		<1%	14	$10K
82533		<1%	903	$10K
86902		<1%	653	$10K
97163		<1%	223	$10K
86364		<1%	1,322	$10K
85730		<1%	4,688	$10K
72158		<1%	63	$10K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,717	$10K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	56	$10K
85014		<1%	5,751	$10K
A9578	Injection, gadobenate dimeglumine (multihance multipack), per ml	<1%	3,153	$10K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	11,078	$10K
82550		<1%	3,689	$9K
90002		<1%	641	$9K
93880		<1%	77	$9K
82565		<1%	2,981	$9K
11102		<1%	25	$9K
92567		<1%	1,212	$9K
72131		<1%	269	$9K
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	<1%	1,700	$9K
76512		<1%	53	$9K
52000		<1%	13	$9K
96132		<1%	166	$9K
80164		<1%	1,266	$9K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	1,234	$9K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	32	$9K
92025		<1%	145	$9K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	35	$9K
86200		<1%	1,017	$8K
11104		<1%	13	$8K
86334		<1%	1,080	$8K
12002		<1%	29	$8K
90710		<1%	671	$8K
G0008	Administration of influenza virus vaccine	<1%	3,367	$8K
86225		<1%	1,157	$8K
94660		<1%	38	$8K
83721		<1%	1,453	$8K
69210		<1%	173	$7K
99157		<1%	808	$7K
96127		<1%	521	$7K
74019		<1%	194	$7K
86431		<1%	1,318	$7K
90716		<1%	124	$7K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,184	$7K
82525		<1%	647	$7K
0054A		<1%	269	$7K
85046		<1%	2,294	$7K
84270		<1%	649	$7K
87338		<1%	749	$7K
84165		<1%	1,548	$7K
64644		<1%	141	$7K
76519		<1%	71	$7K
93247		<1%	174	$7K
64400		<1%	26	$6K
83020		<1%	591	$6K
11900		<1%	27	$6K
86376		<1%	604	$6K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	7,821	$6K
85651		<1%	2,189	$6K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	2,307	$6K
86141		<1%	721	$6K
64642		<1%	103	$6K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	99	$6K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	729	$6K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	2,629	$6K
73060		<1%	286	$6K
84550		<1%	1,950	$6K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	9,550	$6K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	18	$6K
87517		<1%	174	$6K
90021		<1%	412	$6K
86038		<1%	685	$5K
82948		<1%	1,799	$5K
90696		<1%	330	$5K
87075		<1%	1,774	$5K
84703		<1%	1,730	$5K
83002		<1%	519	$5K
83030		<1%	660	$5K
76942		<1%	114	$5K
J2997	Injection, alteplase recombinant, 1 mg	<1%	83	$5K
86160		<1%	827	$5K
91320		<1%	102	$5K
94621		<1%	31	$5K
86708		<1%	728	$5K
88360		<1%	121	$5K
87902		<1%	34	$5K
86301		<1%	644	$5K
84134		<1%	625	$5K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	360	$4K
86849		<1%	1,300	$4K
P9041	Infusion, albumin (human), 5%, 50 ml	<1%	303	$4K
76937		<1%	324	$4K
0071A		<1%	149	$4K
72132		<1%	595	$4K
80299		<1%	508	$4K
96368		<1%	742	$4K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	152	$4K
88313		<1%	549	$4K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	208	$4K
82040		<1%	1,597	$4K
82247		<1%	766	$4K
0297T		<1%	66	$4K
86592		<1%	547	$4K
84480		<1%	397	$4K
82465		<1%	879	$4K
84478		<1%	1,105	$4K
82962		<1%	928	$4K
87147		<1%	785	$4K
A0200	Non-emergency transportation: ancillary: lodging escort	<1%	89	$4K
86800		<1%	422	$4K
84630		<1%	475	$4K
J2060	Injection, lorazepam, 2 mg	<1%	2,003	$4K
62370		<1%	33	$4K
84446		<1%	591	$4K
86147		<1%	135	$4K
84132		<1%	3,759	$4K
82150		<1%	903	$4K
87449		<1%	847	$3K
58301		<1%	15	$3K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	141	$3K
88312		<1%	394	$3K
92235		<1%	41	$3K
86665		<1%	539	$3K
90746		<1%	152	$3K
36416		<1%	2,154	$3K
90480		<1%	132	$3K
77066	Tomosynthesis, mammo	<1%	297	$3K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	529	$3K
84425		<1%	469	$3K
90474		<1%	502	$3K
73700		<1%	44	$3K
20611		<1%	12	$3K
87324		<1%	567	$3K
82947		<1%	3,522	$3K
91312		<1%	1,217	$3K
90656		<1%	120	$3K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	78	$3K
72129		<1%	523	$3K
84155		<1%	1,265	$3K
J1815	Injection, insulin, per 5 units	<1%	4,966	$3K
82248		<1%	843	$3K
80178		<1%	372	$3K
84460		<1%	1,099	$3K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,012	$3K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	18	$2K
96116		<1%	27	$2K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,167	$2K
88262		<1%	50	$2K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	984	$2K
84295		<1%	3,271	$2K
90999	Dialysis (unlisted procedure)	<1%	19	$2K
92523		<1%	62	$2K
51798		<1%	46	$2K
80177		<1%	361	$2K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	134	$2K
82024		<1%	75	$2K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,979	$2K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,094	$2K
86663		<1%	304	$2K
74230		<1%	30	$2K
59425		<1%	15	$2K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	114	$2K
84590		<1%	377	$2K
82610		<1%	221	$2K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	18	$2K
86304		<1%	445	$2K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	996	$2K
43235		<1%	13	$2K
72128		<1%	146	$2K
84520		<1%	695	$2K
82140		<1%	404	$2K
95970		<1%	28	$2K
72110		<1%	38	$2K
80169		<1%	158	$2K
91307		<1%	274	$2K
86664		<1%	304	$2K
82435		<1%	2,987	$2K
76604		<1%	13	$2K
90785		<1%	61	$2K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,890	$2K
74246		<1%	17	$2K
91305		<1%	418	$2K
82390		<1%	149	$2K
94010		<1%	59	$2K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,492	$2K
77062		<1%	81	$2K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	1,393	$1K
0072A		<1%	63	$1K
73120		<1%	45	$1K
96133		<1%	75	$1K
96130		<1%	16	$1K
G0379	Direct admission of patient for hospital observation care	<1%	15	$1K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,397	$1K
90700		<1%	125	$1K
86357		<1%	60	$1K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	380	$1K
82951		<1%	95	$1K
86003		<1%	104	$1K
87102		<1%	525	$1K
80195		<1%	119	$1K
J7070	Infusion, d5w, 1000 cc	<1%	1,316	$1K
80347		<1%	252	$1K
73564		<1%	41	$1K
86644		<1%	151	$1K
85660		<1%	372	$1K
82010		<1%	790	$1K
80179		<1%	4,052	$994.92
84144		<1%	80	$975.82
G0473	Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes	<1%	60	$969.40
88112		<1%	52	$966.78
80143		<1%	4,115	$958.26
94667		<1%	42	$952.04
83521		<1%	410	$939.31
87385		<1%	151	$902.98
82627		<1%	73	$902.33
86696		<1%	133	$898.80
99497		<1%	112	$882.25
80326		<1%	246	$868.32
83525		<1%	76	$864.23
84445		<1%	26	$828.82
86593		<1%	123	$827.05
82103		<1%	114	$811.65
82542		<1%	28	$806.14
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	643	$801.16
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	550	$784.66
88280		<1%	56	$783.86
73620		<1%	34	$782.40
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,270	$764.95
76857		<1%	12	$763.37
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	24	$761.02
85055		<1%	40	$710.61
77065	Tomosynthesis, mammo	<1%	75	$708.51
87807		<1%	50	$697.61
86769		<1%	28	$676.92
83718		<1%	104	$672.56
84450		<1%	279	$661.54
81511		<1%	13	$650.00
92611		<1%	14	$637.37
83993		<1%	51	$620.38
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	1,026	$612.39
81015		<1%	590	$608.60
88271		<1%	41	$594.96
0052A		<1%	18	$582.17
0296T		<1%	15	$579.03
83921		<1%	98	$565.86
62369		<1%	30	$561.88
11100		<1%	12	$543.60
86695		<1%	70	$539.64
96139		<1%	13	$516.32
92593		<1%	33	$514.80
94760		<1%	472	$513.96
Q5105	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units	<1%	23	$512.03
83090		<1%	68	$504.39
90707		<1%	64	$502.64
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,135	$489.83
J3480	Injection, potassium chloride, per 2 meq	<1%	884	$482.03
82952		<1%	96	$453.01
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	980	$452.86
82785		<1%	42	$446.65
L0140	Cervical, semi-rigid, adjustable (plastic collar)	<1%	27	$434.32
80364		<1%	248	$434.07
80355		<1%	248	$434.06
84432		<1%	38	$430.98
C1780	Lens, intraocular (new technology)	<1%	493	$426.47
89051		<1%	432	$417.54
93282		<1%	14	$417.22
80158		<1%	70	$407.62
29125		<1%	14	$407.40
85520		<1%	189	$400.60
86580		<1%	33	$364.35
J7999	Compounded drug, not otherwise classified	<1%	32	$359.83
77001		<1%	51	$348.21
0051A		<1%	13	$347.27
88275		<1%	42	$347.06
70250		<1%	14	$337.26
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	55	$337.00
92136		<1%	14	$332.01
C1729	Catheter, drainage	<1%	468	$328.78
G0009	Administration of pneumococcal vaccine	<1%	896	$319.57
73070		<1%	48	$310.31
70350		<1%	12	$301.13
82274		<1%	28	$300.09
J1956	Injection, levofloxacin, 250 mg	<1%	16	$295.95
83010		<1%	88	$286.76
84207		<1%	55	$281.11
88311		<1%	112	$272.87
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	562	$272.29
Q0239	Injection, bamlanivimab-xxxx, 700 mg	<1%	19	$270.13
G1010	Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program	<1%	9,005	$266.13
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	716	$255.52
86308		<1%	79	$253.82
80349		<1%	33	$232.19
76870		<1%	53	$230.68
84206		<1%	13	$221.32
L3906	Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	<1%	60	$219.19
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	271	$179.92
91308		<1%	17	$174.79
82671		<1%	12	$171.02
86645		<1%	25	$161.90
83883		<1%	18	$145.27
90685		<1%	40	$143.33
85613		<1%	56	$136.99
87116		<1%	135	$129.44
86300		<1%	19	$126.39
86381		<1%	30	$122.38
A0190	Non-emergency transportation: ancillary: meals-recipient	<1%	43	$119.92
83519		<1%	21	$113.12
85670		<1%	56	$109.79
95249		<1%	116	$106.78
87015		<1%	58	$106.56
86341		<1%	15	$106.05
86015		<1%	29	$99.96
C1892	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away	<1%	16	$96.42
87206		<1%	113	$90.00
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,943	$86.49
J7607	Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg	<1%	26	$85.32
86060		<1%	13	$83.16
86709		<1%	16	$76.23
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	<1%	89	$75.91
A9573	Injection, gadopiclenol, 1 ml	<1%	94	$74.10
96040		<1%	599	$68.64
J1940	Injection, furosemide, up to 20 mg	<1%	759	$67.33
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	19	$65.10
J7510	Prednisolone oral, per 5 mg	<1%	32	$60.78
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	196	$58.32
82104		<1%	12	$56.00
91300		<1%	3,389	$45.04
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	19	$41.35
84300		<1%	46	$35.44
83935		<1%	14	$25.40
85384		<1%	20	$24.99
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,153	$18.58
85347		<1%	125	$16.22
98968		<1%	45	$15.40
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	4,070	$7.49
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	108	$6.63
S4990	Nicotine patches, legend	<1%	1,512	$5.31
J8597	Antiemetic drug, oral, not otherwise specified	<1%	27	$5.12
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	276	$4.11
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	156	$2.57
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	495	$0.93
J0461	Injection, atropine sulfate, 0.01 mg	<1%	503	$0.92
J1630	Injection, haloperidol, up to 5 mg	<1%	1,577	$0.90
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	73	$0.07
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	465	$0.01
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	468	$0.01
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	329	$0.01
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	328	$0.01
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	13	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	16	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	76	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	74	$0.00
A6457	Tubular dressing with or without elastic, any width, per linear yard	0%	291	$0.00
96402		0%	67	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	195	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	18	$0.00
J0153	Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)	0%	88	$0.00
92504		0%	28	$0.00
96136		0%	33	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	60	$0.00
J0694	Injection, cefoxitin sodium, 1 gm	0%	29	$0.00
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	0%	30	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	50	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	19	$0.00
96138		0%	13	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	334	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	123	$0.00
95911		0%	14	$0.00
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	67	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	52	$0.00
84157		0%	14	$0.00
92285		0%	16	$0.00
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	0%	24	$0.00
92002		0%	26	$0.00
87071		0%	15	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	40	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	51	$0.00
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	0%	28	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDAUBERT, STEPHANIE (CFO)

Same official

Other billing entities under DAUBERT, STEPHANIE

Full network →

Provider	Location	Paid
Unmc Physicians	Omaha, NE	$41.01M
Bellevue Medical Center LLC	Bellevue, NE	$7.18M
Nebraska Medical Center	Omaha, NE	$62K
Nebraska Medical Center	Omaha, NE	$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.